Trichomonas

Highlighting one notable research article from each Research Roundup in 2023.

Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.

Initial reports from the ongoing narrative collection Care Post Roe documenting poor-quality care, patient perspectives on telehealth medication abortion, adolescent preferences and experiences with pregnancy options counseling, and more.

Importance of a reproductive justice framework in contraceptive counseling, single-dose secnidazole to treat trichomoniasis, timing of post-partum placement of hormonal IUDs, and more.

Intracervical block vs naproxen for pain during IUD insertion, IUD use in transgender and gender-diverse individuals, self-administration of the Depo shot, and more.

Provision of medication abortion via telehealth, updated CDC treatment guidelines for sexually-transmitted infections, barriers to IUD and implant access for adolescent and young adult patients, and more.

Public health benefits of widespread HPV vaccination, potential for IUDs to be placed as emergency contraception 6-14 days after unprotected vaginal sex, etonogestrel implants to help with pelvic pain, and more.

The importance of patient-centered contraceptive counseling, expedited scheduling of interval tubal ligation as a way to improve access to sterilization, a study of barriers to IUD access for adolescent patients, and more.